Skip to Main Content

4,143

Views

8

CrossRef citations to date

0

Altmetric

Meningococcal – Research Paper

Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study

Franco M. Piazzaa Global Clinical Development, Sanofi Pasteur, Swiftwater, PA, USAView further author information

,

Miia Virtab Vaccine Research Center, Tampere University, Tampere, FinlandView further author information

,

Marita Paassiltac Espoo Vaccine Research Clinic, Tampere University, Tampere, FinlandView further author information

,

Benita Ukkonenb Vaccine Research Center, Tampere University, Tampere, FinlandView further author information

,

Anitta Ahonenb Vaccine Research Center, Tampere University, Tampere, FinlandView further author information

,

Alejandra Esteves-Jaramilloa Global Clinical Development, Sanofi Pasteur, Swiftwater, PA, USAView further author information

,

Aino Forstenb Vaccine Research Center, Tampere University, Tampere, FinlandView further author information

,

Ilkka Seppab Vaccine Research Center, Tampere University, Tampere, FinlandView further author information

,

Jian Dingd Biostatistics and Programming, Clinical Scientific Operations, Sanofi, Beijing, ChinaView further author information

,

David Neveue Global Pharmacovigilance, Sanofi Pasteur, Swiftwater, PA, USAView further author information

,

Emilia Jordanova Global Clinical Development, Sanofi Pasteur, Swiftwater, PA, USAView further author information

&

Mandeep S. Dhingraa Global Clinical Development, Sanofi Pasteur, Swiftwater, PA, USACorrespondence[email protected]

https://orcid.org/0000-0002-2507-7165 View further author information